
CytoAgents
Developer of pharmaceutical drugs designed to treat cytokine release syndrome. The company's drugs develop a broadly accessible treatment for multiple indications of high unmet need, including oncolog...
Valuation
$0
Share Price
N/A
Total Raised
$38.6M
Last Round
N/A